chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Client had already received Prevnar-20 vaccination on 6/8/22, data base was not updated, and client was given a second Prevnar-20 on 11/2/22
herpes simplex eruptions x 3 on 7NOV98 & appeared on lips/mucus membranes @ corners of mouth 2 upper & lt lower junctions;h/a x 3 days, general joint discomfort, neck & shoulders;
Immediately after the vaccines I felt soreness and body aches. I also had fevers and numbness on the arm that the injection was administered on. The most serious affect was on my period cycle. I got my period 2 days after injection and then again 2 weeks later. The same thing occurred with the second dosage of this COVID-19 vaccine. I want to know why this happened. I also do not want anymore COVID-19 vaccines.
Vaccine expired on 13 Oct 2021/ refrigerated on 26 Oct 2021/ administered on 01 NOV 2021; 606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine expired on 13 Oct 2021/ refrigerated on 26 Oct 2021/ administered on 01 NOV 2021) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 13 Oct 2021/ refrigerated on 26 Oct 2021/ administered on 01 NOV 2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine expired on 13 Oct 2021/ refrigerated on 26 Oct 2021/ administered on 01 NOV 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The vial was placed in the refrigerator on 26-Oct-2021.Vial did not undergo any temperature excursion. No adverse event was reported.  No treatment medications were reported.
Patient received a 2nd booster dose 4 weeks after his first booster dose and he did not have to receive a 2nd booster dose since he is <50 yrs old. This was reported to patient who felt lightheaded a few hours after vaccination on 7/26 and took a nap. He reported arm pain today. He was advised to call our clinic if has any bothersome side effects in the next few days.
Patient had redness and swelling from mid-forearm to deltoid region.  There was a raised red are at the injection site that remained hard and warm for several days.  The patient denies any fever.
This spontaneous report was received from a medical assistant and refers to a 2 month old patient of unknown gender. No information about the patients pertinent medical history, concomitant medications, drug reactions or allergies was provided. On 26-JUL-2016, the patient was vaccinated with an expired dose ROTATEQ 2 ml, orally, lot # K022993 and expiration date 20-JUL-2016. No adverse effects reported. Additional information has been requested.
Pt cam in 3 days post vax with circular 3cm reddened area on left thigh over vaccine site.
pt rcvd vax; 3hrs later pt began to scream almost unceasingly w/ tremors; pt seen by pediatric;
Case number PHEH2013US017944, is an initial spontaneous report received from a nurse on 22 Aug 2013. This report refers to an 11 years old female patient. She received only Men C, Y, W-135 liquid conjugate component of MENVEO (batch number: X12120), intramuscularly without being reconstituted with Men A lyophilized conjugate vaccine component on 16 Aug 2013. No adverse event was reported following this administration error.
My hands and feet began to swell. My hands became so swollen that I could not make a fist. I then broke out into a full body rash that is indicative of when I am having an allergic reaction (the same as what happens when I take amoxicillin. The doctor gave me a high dose of Benadryl with no relief and then prednisone and a steroid cream. The rash still continues and there is nothing new that I ate or that touched my skin to cause this reaction.
9/4 Fever, rash -> on left arm, dizziness, patient said wife noticed an increase heart rate. 9/5 Patient reported was doing fine now.
Evening of the vaccine I had achiness in both shoulders and neck, but then got chills in the night and body aches , fatigue with headache the next day.  Body aches, fatigue, headache and chills continues into Day 2 with Temp of 100.4 and then felt some swollen neck glands.  Day 3 with Temp 100.2, headache, body aches and fatigue are improving but neck/throat glands more swollen (no nasal congestion but feels like a sinus headache), Day 4- chills (did not check temp), body aches improved, headache continues with swollen sore throat. *I had traveled and flight was 2 days before receiving the vaccine.
This spontaneous report was received from a Physician and refers to an unspecified patient of unknown age and gender. Information regarding pertinent medical history, drug reactions or allergies and concomitant therapy was not provided. On 22-MAR-2017, the patient was vaccinated with improperly stored dose of M-M-R II (lot # M028131 with expiry date 03-JUN-2018) (dose, route and anatomical location not reported) for prophylaxis. Exact time frame and temperature at which the vaccine underwent excursion was unknown. However it was reported that the lot # M028131 underwent a temperature excursion of 32 degrees Fahrenheit to 35 degrees Fahrenheit for a cumulative time frame of 4 hours and a temperature excursion of 47 degrees Fahrenheit to 77 degrees Fahrenheit for a cumulative time frame of 5 hours on different days since 26-JAN-2017 to 27-MAR-2017. Maximum individual time frame was reported as 60 minutes for each cycle. There was no previous temperature excursion. The call was not because of data logger. No adverse effect was reported. This is one of the several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1705USA005435: US-009507513-1705USA005437: US-009507513-1705USA005436: US-009507513-1704USA014447: US-009507513-1705USA005439: US-009507513-1705USA005462: US-009507513-1705USA005463.
Case number PHEH2014US003857 is an initial spontaneous report received from a consumer (patient's father) on 24 FEB 2014. This report refers to a 10-year-old male child. Past medical history and concomitant medications were not reported. He was vaccinated with FLUCELVAX (batch number: unknown), intramuscularly on an unknown date in OCT 2013. No adverse event was reported following this administration error.  Following an internal review on 18 AUG 2014, a significant correction was done for the information received on 24 FEB 2014. The BPI labeling of the event "inappropriate age at vaccine administration" changed from listed to unlisted and added second indication as "adult product administered to child".
Patient developed a rash with welts within 3 hours of being administered Fluzone HD.
This spontaneous case reported by a consumer, describes the occurrence of bronchitis (diagnosed last week) and bronchial asthma in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced bronchitis (diagnosed last week) and bronchial asthma. At the time of the report,  bronchitis (diagnosed last week) and bronchial asthma outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication details reported. Treatment included 2 antibiotics and steroids.
Pt. c/o nausea and vomiting the following day for 24-48 hours. Since resolved.
Lump Rt thigh and red area both size of a dime. No swelling of the leg. Applying cool pack and TYLENOL.
On approximately 5/28 she began having tickle cough with minial mucus production with expiratory wheezing and shortness of breath.  Initially after the vaccine she had mild headache, low grade fever, fatigue and body aches which resolved within 2 days.  The SHOB and wheezing didn't begin until over a week later.  She can relate no other trigger for her asthma and has not had an exacerbation in several years until this.  Note, one letter on vaccine card is unreadable.
Patient had rash.  She went to the doctor and it was diagnosed as shingles.  She had a fever and flu like symptoms preceding the rash.  The rash was on her right breast, arm and back.  She is taking antiviral therapy.
Pain, swelling, redness, inability to walk on affected leg (Left) Treated for cellulitis with Keflex.
local rxn @ injs ite w/redness & swelling the size of a tennis ball pt given a course of pred;
Client c/o general flush feeling dryness of mouth and sweating.  Client verbalized that symptoms occurred immediately after receiving vaccine.  Client seen and assessed by EMS an Vital signs are B/P 147/82, HR 80, O2 100%.  Pt. voice that her anxiety level increased when receiving vaccine but now has decreased and symptoms decreased during observation.  Second round of vitals B/P 139/82, HR 76, O2 99%.  Client then verbalized that she is no longer having the sensation and asked to go home after 45 minutes of observation.  Client denied the need to go to or be taken to the hospital and was cleared to go home by EMS.  No physical reaction noted.
A week after the injection, the injection site is hot, has a lump that is about 3?, has a  large solid red rash, and is itchy and achy.  Picture available if needed.
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about 01-JAN-2016, the patient was inoculated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster. Shortly after being vaccinated in January of 2011 (conflicting information; pt vaccinated in 2016), the patient was treated by a physician for the onset of a vesicular rash, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and. treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
On 08/05/2021, there was a spot on my head that looked unusual. It was itchy, 1 cm or 2 cm in size, dark brown. On that same day, 08/05/2021, I took a picture and sent it to my primary doctor. He told me to come in. He referred me to a dermatologist to do a biopsy. The result of the biopsy- basal cell carcinoma. They gave me an antibiotic at the time of the biopsy. Past history: I was diagnosed with diabetes October 2020. I also have a tear on my Right arm, rotator cuff, I received a cortisone shot on 02/2021. I had Thyroid cancer 24 years ago. I had breast cancer 14 years ago.
My daughter got suddenly very hot. I could feel the heat through her t-shirt on her back. She lost color in her face, and sat down, and fainted (head between her legs).
Fever above 102 for 3 days. Bad rash on torso and face.
ANKLE SWELLING; ARM  SWELLING, FOOT SWELLING; UNABLE TO EAT; GENERALIZED ITCHING; SWELLING; ARTHRITIS AGGRAVATED; REDNESS IN THE KNEES AND LEGS; NOT FEELING GOOD; PAIN; ARM TENDER, ARM PAIN; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included arthritis, and other pre-existing medical conditions included patient had bacteria on her side (pre-existing conditions). The patient was previously treated with codeine/paracetamol for pain. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025, and batch number: 1805025 expiry: 25-MAY-2021) dose was not reported, administered on 06-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced ankle swelling. On MAR-2021, the subject experienced arm swelling, foot swelling. On MAR-2021, the subject experienced unable to eat. On MAR-2021, the subject experienced generalized itching. On MAR-2021, the subject experienced swelling. On MAR-2021, the subject experienced arthritis aggravated. On MAR-2021, the subject experienced redness in the knees and legs. On MAR-2021, the subject experienced not feeling good. On MAR-2021, the subject experienced pain. On MAR-2021, the subject experienced arm tender, arm pain. Treatment medications (dates unspecified) included: xipamide. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from arm swelling, foot swelling, had not recovered from pain, and arm tender, arm pain, and the outcome of ankle swelling, not feeling good, redness in the knees and legs, unable to eat, generalized itching, swelling and arthritis aggravated was not reported. This report was non-serious.
Varivax given in right post. arm 11/30/07.  Began with redness and swelling later that continued to progress.  Was seen 12/3/07, area measured 14cm x 15cm, was red & hot.  Suspected cellulitis.  Started on Duricef 1gm twice daily.
Hives rash all over body. Onset at 1230 on 11/24/11. Cleared at 1400 on 11/24/11.
Patient was administered 1st Moderna vaccine on 5/5/2021 and 2nd Moderna vaccine on 6/3/2021. She is 16 years old and therefore outside the approved vaccination age. No symptoms during observation period.
I'm experiencing  extreme fatigue where I will take involuntary naps during the day and sleeping more than 8 hours a night. Normally I struggle with not sleeping enough and am not sure if it's directly related to the vaccine but I wanted to give the data in case it was.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown age and gender. Medical history and drug reactions/allergies were not reported. On 07-AUG-2014, the patient was vaccinated with an expired M-M-R II, subcutaneously, expiry date 03-AUG-2014 (lot and dose not reported). Concomitant medications was not reported. No adverse effects reported. At the time of the report, action taken regarding therapy with M-M-R II was not reported. Additional information has been requested.
Pt reports some mild soreness (L) arm within 24 hours after Td immunization on (L) deltoid. States this soreness resolved. Then about 1 week later experienced (L) deltoid pain, which persists. Pt is unaware of any injury to this area. On on exam, very faint redness at a 1 cm diameter area located at lower edge of (L) deltoid approximately 5 cm below injection site. No palpable lesion.
Nausea, high fever, weakness, body aches, shortness of breath, lethargy.
eyes burned-h/a mild-severe-difficulty breathing; blacked-out (pt had a car accident) sent back to clinic-broken jaw, teeth wired closed, lacerated under lip
Developed cellulitis in L arm quarter size. 2/8/06 Dad called, son has cellulitis on L arm where Pediarix was given 10-31-05 given antibiotics, info given to Dr. 2-13-06 called Dr. she asked me to call dad and find out particular. Spoke with dad, son developed redness and cellulitis. The next day approx 1 1/2 months later after itching/digging at area he began to have a pus like discharge from L arm where inj. were given. Approx 2 wks later they took him to Dr and were told that it was cellulitis and he was placed on antibiotic course. That didn't seem to help so he was placed on another antibiotic, area is getting smaller. I have a call into Dr office to find out what antibiotics were given. VAERS report filed.
My symptoms include:  - Piercing headache(migraine) - Light sensitivity - Nausea - Chills - Strange bowel movements(diarreah)  Ongoing since last Wednesday 04/14/2021
Nausea, something in throat, involuntary finger movement, especially in left hand. Benadryl 50 mg IM given.
Patient began experience the sensation of her throat closing and mild peri-oral swelling.  Patient's epi pen was adminsted along with 50 mg of Benadry
Mild fever progressed into high fever over the next three days, and went up and down -- presumably gone as of 05/09/2010.  Irritability and diminished appetite lasted for first three days, as did cold-like symptoms, including congestion and labored breathing.  Lymph nodes near base of neck have remained swollen the entire time, and a slight rash has developed as of 05/07/2010 on face and abdomen.  Also, there were three instances of white or pale stool between 05/04/2010 and 05/06/2010.
"Asyncope followed by apparent seizure activity. Palor, stiffness with jerking motion of muscles to extremities. Pt. lost conciousness multiple times (2 to 3). Patient was transported to hospital via EMS
I  ended up in the ER on 6/4/21 with a BP of 186/125, fluttering heart, etc?Several tests were done and I was told my HEART WAS ENLARGED which has never been noted before. I?ve had extreme fatigue since.
reaction after three days; wasn't feeling well; too weak to get ready to go; getting fatigue; muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (reaction after three days), MALAISE (wasn't feeling well), ASTHENIA (too weak to get ready to go), FATIGUE (getting fatigue) and MYALGIA (muscle pain) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Lot# 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced ADVERSE REACTION (reaction after three days), MALAISE (wasn't feeling well), ASTHENIA (too weak to get ready to go), FATIGUE (getting fatigue) and MYALGIA (muscle pain). At the time of the report, ADVERSE REACTION (reaction after three days), MALAISE (wasn't feeling well), ASTHENIA (too weak to get ready to go), FATIGUE (getting fatigue) and MYALGIA (muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient stated that I just got my first dose of Moderna vaccine last Friday on 26feb2021 and I was fine until now. Today I started getting fatigue and muscle pain. I had doctor's appointment but I wasn't feeling well so I couldn't go. I was too weak to get ready to go. Is it okay to get the reaction after three days?
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 63-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX with an associated reaction of pain in extremity (For tolerance to 1st dose please refer case US2018170973). On 23rd November 2018, the patient received the 2nd dose of SHINGRIX (intramuscular) .5 ml. On 23rd November 2018, less than a day after receiving SHINGRIX, the patient experienced pain in arm, injection site swelling, tiredness, upset stomach, appetite lost, shivering, shoulder pain, back pain and injection site tenderness. On 24th November 2018, the patient experienced headache, generalized aching and influenza like illness. Rechallenge with SHINGRIX was positive. On 25th November 2018, the outcome of the injection site swelling, tiredness, upset stomach, appetite lost, shivering, shoulder pain, back pain, headache, generalized aching and influenza like illness were recovered/resolved. On an unknown date, the outcome of the pain in arm and injection site tenderness were not recovered/not resolved. It was unknown if the reporter considered the pain in arm, injection site swelling, tiredness, upset stomach, appetite lost, shivering, shoulder pain, back pain, headache, generalized aching, influenza like illness and injection site tenderness to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX on her left arm at 11:30 am. Within two hours after receiving the vaccination, the patient developed severe soreness in her left arm and that extended from her left shoulder almost to her left hand. Also, the injection site began to swell. Four hours after the vaccination she began to feel extremely tired and had an upset stomach, causing her to lose her appetite and not be able to eat her dinner. Eight hours after the injection, the patient started shivering and went to bed having soreness in both shoulders and her back. On 24th November 2018, 1 day after receiving SHINGRIX, the patient was shivering, felt severely tired, had a headache, and had to take naps all day. She had aches all over her upper body and described that she felt like she had the flu. On 25th November 2018, Sunday, the patient woke up and all symptoms had resolved other than the injection site is a little sore if she presses on it. The reporter gave permission for her physician to be contacted.
The patient began to feel dizziness three minutes after receiving the vaccine. Nausea, chest pain, shortness of breath, blurry vision. Respirations even and unlabored. Vital signs at 12:20 pm: BP 105/76, HR 77, Resp. 18 breathes/min, SAT 100% , Temperature 97.6. Patient instructed to remain sitting with legs slightly elevated. Signs and symptoms rescheduled at 12:26. Patient observed for additional time. Vital signs at 12:36 pm: BP 122/80, HR 80, O2 SAT 100%, Resp. 20, Temperature 97.5. Patient's gait steady and stable. Patient released with husband and two children. All present throughout the observation period. No distress stated.
A mother reported that her 3-month-old received a 1st dose of Prevnar vaccine in July 2001. Additional suspect vaccine included DTaP vaccine (diptheria and tetanus toxoids and acellular pertussis) (manufacturer unknown). The physician told the mother that the nurse had inadvertently injected the Prevnar into the infant's fat, not her muscle. Several hours post immunization, the infant developed a fever and an injection site reaction characterized by rash, redness and a hard, golf ball size, lump. The lump under the skin lasted for several weeks. No additional information was available as of the date of this report. Follow-up info received on 12/12/2001. The infant was seen in Urgent Care on 08/17/2001. She was treated with symptomatic local care of cold compresses and Tylenol prn.
He is 15 male; He is 15 male; High fever of 102 post first Covid vaccine; This is a spontaneous report received from a contactable consumer. A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection) via an unspecified route of administration on an unspecified date (Lot Number: EW1076) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced high fever of 102 post first Covid vaccine. He was 15 male on an unspecified date. Event took place after use of product. The patient underwent lab tests and procedures which included body temperature: 102 on an unspecified date. Outcome of fever of 102 was unknown.    No follow-up attempts are needed. No further information is expected.
pt recvd vax;pain in rt knee & limp in mid dec93 following a fall, and vax;
Shaking, freezing cold, hands wouldn?t close, couldn?t get warm, couldn?t sleep
Small red bumps around eyes with a small amount of swelling.  No wheezing, difficulty breathing.